Shanghai - Delayed Quote CNY
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (600721.SS)
6.63
-0.04
(-0.60%)
At close: April 30 at 3:00:04 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Hui Huang | Rotating GM & Director | -- | -- | 1984 |
| Ms. Ziyun Cai | Chief Financial Officer | -- | -- | 1973 |
| Mr. Zhengtian Lu | Executive Deputy GM & Director | -- | -- | 1964 |
| Mr. Yan Xia | Deputy GM & Director | -- | -- | 1980 |
| Tao Yu | Accounting Supervisor | -- | -- | -- |
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
No. 1, South Lane
Zhongshan Road Tianshan District
Urumqi, 830002
China
- Sector:
- Consumer Cyclical
- Industry: Restaurants
- Full Time Employees:
- 731
Description
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses. The company was formerly known as Xinjiang Baihuacun Co., Ltd. and changed its name to Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021. Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd was founded in 1959 and is based in Urumqi, China.
Corporate Governance
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 22, 1997 at 12:00 AM UTC
Ex-Dividend Date